Ian Thomas / CNBC ·
Thyme Care, which focuses on filling cancer treatment gaps via a virtual navigation platform, raised a $125M Series E at a $2B+ valuation, up from $1B+ in 2025
Despite recent advancements in oncology, the branch of medicine focused on the study, prevention, diagnosis and treatment of cancer …